文献速递慢性静脉疾病

射频消融术后静脉内热诱导血栓形成(EHIT)的危险因素分析

Determining Risk Factors for Endovenous Heat-induced Thrombosis after Radiofrequency Ablation.
PubMed 文献 · Ann Vasc Surg · 2020-09-18

该单中心回顾性研究分析了2016至2019年间接受射频消融(RFA)的642例患者,发现EHIT发生率为6.6%。左侧股总静脉或右侧股静脉功能不全、同期行点式剥脱和硬化剂治疗(左侧)、糖尿病以及治疗左侧静脉中位直径1.2 cm与EHIT或其高级别相关。无论采取何种管理方式,超过50%的EHIT在随访中改善。

要点

  • EHIT发生率为6.6%,左侧股总静脉或右侧股静脉功能不全是危险因素。
  • 糖尿病和治疗左侧静脉中位直径1.2 cm与高级别EHIT(III-IV级)相关。
  • 超过50%的EHIT在随访中消退或降级,与所选管理方式无关。

核心结论

  • 左侧股总静脉或右侧股静脉功能不全在总EHIT组中更常见。
  • 糖尿病和治疗左侧静脉中位直径1.2 cm在高级别EHIT组中更常见。
  • 超过50%的EHIT在随访中改善,无论管理方式如何。

研究设计与样本

  • 单中心回顾性分析,纳入2016至2019年接受RFA的18岁以上患者,共642例符合标准。

主要发现

  • 642例RFA手术中,EHIT发生43例(6.6%)。
  • EHIT组中左侧股总静脉功能不全更常见(P=0.024),右侧股静脉功能不全也更常见(P=0.011)。
  • 左侧同时行点式剥脱和硬化剂治疗与RFA联用可能增加EHIT风险(P=0.021)。
  • 糖尿病患者更可能出现高级别EHIT(III-IV级)(P=0.05)。
  • 治疗左侧静脉中位直径1.2 cm的患者更可能出现高级别EHIT(P=0.02)。

关键数值与推荐

  • EHIT管理方式包括阿司匹林(44%)、抗凝(28%)、两者兼用(10%)或均未使用(18%)。
  • 随访时EHIT消退或降级占64%,无变化占5%,进展占8%。

临床怎么用

  • 对于存在左侧股总静脉或右侧股静脉功能不全、糖尿病或治疗左侧静脉直径较大(如1.2 cm)的患者,RFA术后应警惕EHIT发生及高级别EHIT可能。
  • 左侧同期行点式剥脱和硬化剂治疗可能增加EHIT风险,需权衡联合手术策略。
  • 多数EHIT在随访中改善,但需个体化管理并监测进展。

局限性

  • 回顾性单中心设计可能引入选择偏倚。
  • 样本量有限,需更大样本进一步验证变量与EHIT的关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The objective of this study was to evaluate risk factors, incidence, management, and outcome of endovenous heat-induced thrombosis (EHIT) related to radiofrequency ablation (RFA). METHODS: This was a single-center retrospective analysis of patients over the age of 18 who underwent RFA between 2016 and 2019. Demographics, comorbidities, medications, severity scores, vascular anatomy, procedural details, and outcome data were collected. EHIT-related data included occurrence, grade, laterality, management, and outcome. RESULTS: During the study period, 672 RFA procedures were performed at our institution. Of these, 642 (median age 57 (21-93), 62.3% female) met study inclusion criteria. EHIT was observed in 43 (6.6%) cases. Concurrent left common femoral vein (CFV) or right femoral vein (FV) incompetence was found to be more prevalent in the EHIT group (P = 0.024 and P = 0.011, respectively). Compared with performing RFA alone, concurrent performance of stab phlebectomy and sclerotherapy with RFA on the left side was found to be associated with possible increased risk for EHIT (P = 0.021). Furthermore, patients with diabetes mellitus (DM) (P = 0.05) and those with median diameter of the treated left vein of 1.2 cm (P = 0.02) were more likely to have a higher EHIT grade (III and IV) than those without DM and those with smaller vein diameter, respectively. Management included aspirin (44%), anticoagulant (28%), both (10%), or neither (18%). EHIT either resolved or regressed (64%), did not change (5%), or propagated (8%) at follow-up. CONCLUSIONS: Left CFV or right FV incompetence was found to be more prevalent in the total EHIT group. Furthermore, DM and the median size of the treated vein on the left (1.2 cm) were more prevalent in the high (III-IV) versus low grade (I-II) EHIT group. More than 50% of EHIT improved (regressed or resolved) at follow-up regardless of the management option. Further analysis with larger patient samples are needed to confirm the association between these variables and the development of EHIT.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Skeik N, Murray B, Carlson C, et al. Determining Risk Factors for Endovenous Heat-induced Thrombosis after Radiofrequency Ablation. Ann Vasc Surg. 2020. PMID: 32950624. doi:10.1016/j.avsg.2020.08.148

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。